CLINICAL TRIALS BY STATE

Clinical Trials in Mississippi

12+ recruiting studies in Mississippi, updated in real time and displayed in plain English.

BROWSE BY CONDITION IN MISSISSIPPI

Bladder CancerBrain Tumor / GliomaBreast CancerCervical CancerColorectal CancerEndometrial / Uterine CancerHead & Neck CancerKidney / Renal Cell CarcinomaLeukemia (AML)Leukemia (CLL)Liver / Hepatocellular CarcinomaLung Cancer (NSCLC)Lung Cancer (SCLC)Lymphoma (Non-Hodgkin)MelanomaMultiple MyelomaOvarian CancerPancreatic Cancer

RECRUITING TRIALS IN MISSISSIPPI

RECRUITINGPhase 1

Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis

NCT06619990 · Scottsdale, Xencor Investigative Site
RECRUITINGPhase 3

Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)

NCT06170788 · Phoenix, Mayo Clinic in Arizona - Phoenix ( Site 0147)
RECRUITINGPhase 2

Radiation Therapy With or Without Cisplatin in Treating Patients With Stage III-IVA Squamous Cell Carcinoma of the Head and Neck Who Have Undergone Surgery

NCT02734537 · Birmingham, University of Alabama at Birmingham Cancer Center
RECRUITINGPhase 3

Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer

NCT07222566 · Bullhead City, Pioneer Research Center
RECRUITING

Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects

NCT04242095 · Anchorage, Anchorage Associates in Radiation Medicine
RECRUITINGPhase 3

A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

NCT05183646 · Birmingham, University of Alabama at Birmingham
RECRUITINGPhase 2

Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare

NCT07145229 · Peoria, Onyx Clinical Research
RECRUITINGPhase 2

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

NCT07215390 · Gilbert, Associated Retina Consultants (01065)
RECRUITINGNA

A Mobile Gaming App to Improve Adherence to PrEP

NCT05762705 · Boston, Boston Medical Center
RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of KarXT for the Treatment of Manic Episodes in Bipolar-I Disorder (BALSAM-2)

NCT06951711 · Little Rock, Pillar Clinical Research- Little Rock
RECRUITING

Evaluating Obesity-Mediated Mechanisms of Pancreatic Carcinogenesis in Minority Populations

NCT05687188 · Tampa, Moffitt Cancer Center
RECRUITINGNA

Evaluating the Efficacy of NeoThelium FT in the Treatment of Chronic Open Wounds

NCT06918561 · Denham Springs, MedCentris of Denham Springs

COMMON QUESTIONS

How many clinical trials are available in Mississippi?

There are currently 12+ recruiting clinical trials in Mississippi listed on ClinicalTrials.gov. Clinicals AI makes these easier to browse with plain-language summaries and condition filters.

How do I join a clinical trial in Mississippi?

Browse the listings above, review eligibility criteria, and submit a contact request. A study coordinator will follow up to discuss your eligibility and next steps.

Are clinical trials in Mississippi free?

Most trials cover the investigational treatment and study-related visits at no cost. Some also offer compensation for time and travel. Confirm cost details with each trial coordinator.

What conditions have trials in Mississippi?

Mississippi hosts trials across cancer, cardiovascular disease, diabetes, neurological conditions, mental health, autoimmune disease, and rare conditions. Browse by condition using the links above.

OTHER STATES

CaliforniaNew YorkTexasFloridaPennsylvaniaOhioIllinoisMassachusettsMichiganWashington